期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Paclitaxel induces human KOSC3 oral cancer cell apoptosis through caspase pathways
1
作者 YU-YAN LAN TSUN-CHIH CHENG +2 位作者 YI-PING LEE CHIA-YIH WANG BU-MIIN HUANG 《BIOCELL》 SCIE 2024年第7期1047-1054,共8页
Background:Paclitaxel is a compound derived from Pacific yew bark that induces various cancer cell apoptosis.However,whether it also has anticancer activities in KOSC3 cells,an oral cancer cell line,is unclear.Methods:... Background:Paclitaxel is a compound derived from Pacific yew bark that induces various cancer cell apoptosis.However,whether it also has anticancer activities in KOSC3 cells,an oral cancer cell line,is unclear.Methods:3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide,flow cytometry,and western blotting assays were carried out to assess cell viability,subG1 phase of the cell cycle,and apoptosis-related protein expression,respectively.Results:Ourfindings indicate that paclitaxel could inhibit cell viability and increase the expression of apoptotic markers,including plasma membrane blebbing and the cleavage of poly ADP-ribose polymerase in KOSC3 cells.Also,the treatment with paclitaxel remarkably elevated the percentage of the subG1 phase in KOSC3 cells.In addition,treatment with a pan-caspase inhibitor could recover paclitaxel-inhibited cell viability.Moreover,caspase-8,caspase-9,caspase-7,and BH3 interacting domain death agonist(Bid)were activated in paclitaxel-treated KOSC3 cells.Conclusions:Paclitaxel induced apoptosis through caspase cascade in KOSC3 cells. 展开更多
关键词 PACLITAXEL Oral cancer KOSC3 cells APOPTOSIS caspase pathways
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部